{"text": ["AbbVie's", "HCV", "Drug", "Mavyret", "Succeeds", "in", "Label", "Expansion", "Study"], "created_at": "2018-11-14 22:08:11"}
{"text": ["AbbVie's", "HCV", "Drug", "Mavyret", "Succeeds", "in", "Label", "Expansion", "Study"], "created_at": "2018-11-14 22:08:11"}
{"text": ["Migraine-Focused", "Biotech", "Has", "A", "Headache", "On", "Quarterly", "Losses"], "created_at": "2018-11-14 21:06:27"}
{"text": ["AbbVie&apos;s", "HCV", "Drug", "Mavyret", "Succeeds", "in", "Label", "Expansion", "Study"], "created_at": "2018-11-14 20:34:08"}
{"text": ["Merck", "Starts", "Rolling", "BLA", "Submission", "for", "Ebola", "Vaccine", "V920"], "created_at": "2018-11-14 17:12:24"}
{"text": ["Merck", "Starts", "Rolling", "BLA", "Submission", "for", "Ebola", "Vaccine", "V920"], "created_at": "2018-11-14 17:12:24"}
{"text": ["Merck", "Starts", "Rolling", "BLA", "Submission", "for", "Ebola", "Vaccine", "V920"], "created_at": "2018-11-14 15:15:03"}
{"text": ["Shire's", "Filing", "Accepted", "by", "FDA", "for", "Gattex's", "Label", "Expansion"], "created_at": "2018-11-14 14:09:41"}
{"text": ["Shire's", "Filing", "Accepted", "by", "FDA", "for", "Gattex's", "Label", "Expansion"], "created_at": "2018-11-14 14:09:41"}
{"text": ["Shire&apos;s", "Filing", "Accepted", "by", "FDA", "for", "Gattex&apos;s", "Label", "Expansion"], "created_at": "2018-11-14 13:02:01"}
{"text": ["Eli", "Lilly", "announces", "progress", "on", "new", "headache", "medications"], "created_at": "2018-11-14 12:52:00"}
{"text": ["Lilly", "Submits", "New", "Drug", "Application", "to", "the", "FDA", "for", "Lasmiditan", "for", "Acute", "Treatment", "of", "Migraine,", "Receives", "Breakthrough", "Therapy", "Designation", "for", "Emgality\u2122", "(galcanezumab-gnlm)", "for", "Prevention", "of", "Episodic", "Cluster", "Headache"], "created_at": "2018-11-14 11:45:00"}
